Citadel Advisors’s Vanda Pharmaceuticals VNDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$698K Sell
147,797
-100,309
-40% -$473K ﹤0.01% 3683
2025
Q1
$1.14M Sell
248,106
-132,979
-35% -$610K ﹤0.01% 3146
2024
Q4
$1.83M Buy
381,085
+238,650
+168% +$1.14M ﹤0.01% 2703
2024
Q3
$668K Sell
142,435
-5,001
-3% -$23.5K ﹤0.01% 3496
2024
Q2
$833K Sell
147,436
-577,803
-80% -$3.26M ﹤0.01% 3240
2024
Q1
$2.98M Buy
725,239
+106,233
+17% +$437K ﹤0.01% 2151
2023
Q4
$2.61M Sell
619,006
-65,147
-10% -$275K ﹤0.01% 2190
2023
Q3
$2.96M Buy
684,153
+48,639
+8% +$210K ﹤0.01% 2046
2023
Q2
$4.19M Sell
635,514
-382,687
-38% -$2.52M ﹤0.01% 1846
2023
Q1
$6.91M Buy
1,018,201
+469,872
+86% +$3.19M ﹤0.01% 1569
2022
Q4
$4.05M Buy
548,329
+460,594
+525% +$3.4M ﹤0.01% 1971
2022
Q3
$867K Buy
87,735
+52,058
+146% +$514K ﹤0.01% 3550
2022
Q2
$389K Buy
+35,677
New +$389K ﹤0.01% 4379
2022
Q1
Hold
0
7175
2021
Q4
Sell
-39,200
Closed -$672K 7247
2021
Q3
$672K Sell
39,200
-69,324
-64% -$1.19M ﹤0.01% 4215
2021
Q2
$2.33M Sell
108,524
-63,625
-37% -$1.37M ﹤0.01% 3033
2021
Q1
$2.59M Sell
172,149
-71,826
-29% -$1.08M ﹤0.01% 2883
2020
Q4
$3.21M Sell
243,975
-700,360
-74% -$9.2M ﹤0.01% 2147
2020
Q3
$9.12M Buy
944,335
+50,284
+6% +$486K ﹤0.01% 1150
2020
Q2
$10.2M Buy
894,051
+592,275
+196% +$6.78M ﹤0.01% 1070
2020
Q1
$3.13M Sell
301,776
-21,658
-7% -$224K ﹤0.01% 1829
2019
Q4
$5.31M Sell
323,434
-90,007
-22% -$1.48M ﹤0.01% 1604
2019
Q3
$5.49M Buy
413,441
+361,974
+703% +$4.81M ﹤0.01% 1597
2019
Q2
$725K Sell
51,467
-73,937
-59% -$1.04M ﹤0.01% 3241
2019
Q1
$2.31M Sell
125,404
-46
-0% -$846 ﹤0.01% 2198
2018
Q4
$3.28M Sell
125,450
-296,849
-70% -$7.76M ﹤0.01% 1807
2018
Q3
$9.69M Buy
422,299
+280,979
+199% +$6.45M ﹤0.01% 1111
2018
Q2
$2.69M Buy
141,320
+63,906
+83% +$1.22M ﹤0.01% 1915
2018
Q1
$1.3M Sell
77,414
-54,186
-41% -$913K ﹤0.01% 2261
2017
Q4
$2M Sell
131,600
-658,785
-83% -$10M ﹤0.01% 1903
2017
Q3
$14.1M Buy
790,385
+291,867
+59% +$5.22M 0.01% 790
2017
Q2
$8.13M Buy
498,518
+53,833
+12% +$877K 0.01% 952
2017
Q1
$6.23M Buy
444,685
+288,502
+185% +$4.04M 0.01% 1109
2016
Q4
$2.49M Buy
156,183
+102,160
+189% +$1.63M ﹤0.01% 1390
2016
Q3
$899K Buy
54,023
+36,531
+209% +$608K ﹤0.01% 2030
2016
Q2
$196K Sell
17,492
-43,251
-71% -$485K ﹤0.01% 2821
2016
Q1
$508K Sell
60,743
-49,072
-45% -$410K ﹤0.01% 2206
2015
Q4
$1.02M Sell
109,815
-24,585
-18% -$229K ﹤0.01% 1965
2015
Q3
$1.52M Buy
134,400
+28,107
+26% +$317K ﹤0.01% 1925
2015
Q2
$1.35M Buy
106,293
+61,346
+136% +$779K ﹤0.01% 1968
2015
Q1
$418K Sell
44,947
-36,730
-45% -$342K ﹤0.01% 2752
2014
Q4
$1.17M Buy
81,677
+80,137
+5,204% +$1.15M ﹤0.01% 2015
2014
Q3
$16K Sell
1,540
-35,110
-96% -$365K ﹤0.01% 3385
2014
Q2
$593K Sell
36,650
-33,869
-48% -$548K ﹤0.01% 2172
2014
Q1
$1.15M Sell
70,519
-311,118
-82% -$5.06M ﹤0.01% 1768
2013
Q4
$4.74M Buy
381,637
+321,275
+532% +$3.99M 0.01% 1009
2013
Q3
$662K Sell
60,362
-32,294
-35% -$354K ﹤0.01% 1765
2013
Q2
$749K Buy
+92,656
New +$749K ﹤0.01% 1781